Reference Source

0409-0001-25 · Midazolam Hydrochloride Injection · Hospira, Inc., a Pfizer Company

What is the package ndc for 0409-0001-25 · Midazolam Hydrochloride Injection · Hospira, Inc., a Pfizer Company?

For 0409-0001-25 · Midazolam Hydrochloride Injection · Hospira, Inc., a Pfizer Company, package ndc is 0409-0001-25; generic name is Midazolam Hydrochloride Injection; manufacturer is Hospira, Inc., a Pfizer Company; status is Current; availability now is Limited Availability, recorded from its source on 2026-09-15.

"initial_posting_date": "04/02/2020", "package_ndc": "0409-0001-25", "generic_name": "Midazolam Hydrochloride Injection", "contact_info": "844-646-4398", "availability": "Limited Availability", "related_info": "Next Delivery and Estimated Recovery: December 2026"

api.fda.gov, retrieved 2026-09-15

Package NDC
0409-0001-25 verified
Generic name
Midazolam Hydrochloride Injection verified
Manufacturer
Hospira, Inc., a Pfizer Company verified
Status
Current verified
Availability now
Limited Availability verified
FDA note
Next Delivery and Estimated Recovery: December 2026 verified
Initial posting date
04/02/2020 verified
Last update date
09/11/2026 verified
Days in shortage
2357 our reading
Reason for shortage
Demand increase for the drug verified
Dosage form
Injection verified
Therapeutic category
Anesthesia verified
Sourceapi.fda.gov
Verified
Review by
DatasetFDA drug shortage duration tracker

Values marked our reading are our classification of what the source says — the source does not print them in those words. The quote below is the evidence for each one; judge it yourself.

Where each value comes from

The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.

Manufacturer, Status, Last update date, Reason for shortage, Dosage form and Therapeutic category

"update_date": "09/11/2026", "therapeutic_category": [ "Anesthesia", "Neurology" ], "dosage_form": "Injection", "presentation": "Midazolam Hydrochloride Preservative Free, Injection, 2 mg/2mL (1 mg/mL) (NDC 0409-0001-25)", "company_name": "Hospira, Inc., a Pfizer Company", "shortage_reason": "Demand increase for the drug", "status": "Current"

— all from api.fda.gov, retrieved 2026-09-15

Source

Last verified against source: . Due for re-check by . This page as Markdown · OKF bundle · full dataset as JSON.